Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 FEV1 (L) at 16 hours post-dose after a single inhalation of either SFC (50/100 mcg), FBC (4.5/160 mcg) or placebo (Study A).

From: Inhaled steroid/long-acting β2 agonist combination products provide 24 hours improvement in lung function in adult asthmatic patients

  Placebo (n = 33) SFC (n = 33) FBC (n = 33)
Baseline adjusted mean (se) 2.74 (0.04) 3.01 (0.04) 3.03 (0.04)
Adjusted mean change at 16 hours from baseline (se) -0.05 (0.04) 0.22 (0.04) 0.25 (0.04)
   SFC vs placebo FBC vs placebo
Statistical difference (se)   0.27 (0.04) 0.29 (0.04)
95% CI   0.19, 0.35 0.21, 0.37
P value   <0.001 <0.001
   SFC vs FBC  
Statistical difference (se)   -0.02 (0.04)  
95% CI   -0.10, 0.06  
P value   0.617